Literature DB >> 13520434

Studies directed toward the use of antibodies as carriers of radioactivity for therapy.

W F BALE, I L SPAR.   

Abstract

Keywords:  ANTIBODIES; RADIOTHERAPY

Mesh：

Substances：

Year:  1957        PMID： 13520434     DOI： 10.1016/b978-1-4832-3111-2.50011-0

Source DB:  PubMed          Journal:  Adv Biol Med Phys        ISSN： 0065-2245


× No keyword cloud information.
  8 in total

1.  Cancer and the radiotherapist.

Authors:  A M JELLIFFE
Journal:  Postgrad Med J       Date:  1961-06       Impact factor: 2.401

Review 2.  Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy.

Authors:  Robert M Sharkey; Edmund A Rossi; William J McBride; Chien-Hsing Chang; David M Goldenberg
Journal:  Semin Nucl Med       Date:  2010-05       Impact factor: 4.446

Review 3.  Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer.

Authors:  A R Fritzberg; R W Berninger; S W Hadley; D W Wester
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

4.  Can radioimmunotherapy promote from an orphan drug to daily clinical practice?

Authors:  Felix M Mottaghy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05       Impact factor: 9.236

5.  A new immunoradioactive agent: 32P-conjugated antibody.

Authors:  R A Spence; J M Swan; W G De Boer; T Ghose; R C Nairn; J M Rolland; H A Ward; S H Wright
Journal:  Clin Exp Immunol       Date:  1968-10       Impact factor: 4.330

6.  Early diagnosis of ovarian cancer.

Authors:  D R Popkin
Journal:  Can Med Assoc J       Date:  1979-05-05       Impact factor: 8.262

Review 7.  Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.

Authors:  Tapan K Nayak; Martin W Brechbiel
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

8.  Enhanced tumor retention of radioiodinated anti-epidermal growth factor receptor antibody using novel bifunctional iodination linker for radioimmunotherapy.

Authors:  Eun Jung Kim; Byoung Soo Kim; Dan Bee Choi; Sung-Gil Chi; Tae Hyun Choi
Journal:  Oncol Rep       Date:  2016-03-24       Impact factor: 3.906
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.